- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Immupharma PLC (25I)
| Open: | 0.432 | Day's Range: | 0.432 - 0.435 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.397 | 52wk Range: | 0.375 - 0.870 | 1-Yr Rtn: | -41.77% |
Key Statistics for 25I
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (12/2013) | -0.0470 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 25I
Company Profile & Key Executives for 25I
Immupharma PLC is a pharmaceutical company. The Company researches treatments for lupus, cancer, post-operative pain, and highly resistant hospital-acquired infections.
| Dimitri F DimitriouChief Executive Officer | Robert ZimmerPresident/Chief Scientific Ofcr |
| Tracy WeimarVP:Operations/Secretary | Lisa BaderoonHead:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
25I News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page